HAMP and atherosclerosis: To further evaluate the diagnostic utility of hepcidin as a predictor of subclinical atherosclerosis, we performed receiver operating characteristic (ROC) curve analysis using CIMT ≥ 0.9 mm as the threshold for high-risk patients (Figure 3).